BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1036 related articles for article (PubMed ID: 27864201)

  • 1. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic.
    Raheem F; Kim P; Grove M; Kiel PJ
    Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32182657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.
    Valgus J; Weitzel KW; Peterson JF; Crona DJ; Formea CM
    Am J Health Syst Pharm; 2019 Apr; 76(8):521-529. PubMed ID: 31361863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of pharmacists into a patient-centered medical home.
    Scott MA; Hitch B; Ray L; Colvin G
    J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
    Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ
    J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevating pharmacists' scope of practice through a health-system clinical privileging process.
    Jordan TA; Hennenfent JA; Lewin JJ; Nesbit TW; Weber R
    Am J Health Syst Pharm; 2016 Sep; 73(18):1395-405. PubMed ID: 27413142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
    Hanson RL; Habibi M; Khamo N; Abdou S; Stubbings J
    Am J Health Syst Pharm; 2014 Mar; 71(6):463-9. PubMed ID: 24589537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
    Owusu-Obeng A; Weitzel KW; Hatton RC; Staley BJ; Ashton J; Cooper-Dehoff RM; Johnson JA
    Pharmacotherapy; 2014 Oct; 34(10):1102-12. PubMed ID: 25220280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team.
    Ignoffo RJ; Knapp KK; Seung A; Brown V; Hough S; Rieband G; Dang TO; Palumbo A; Urmanski A
    J Oncol Pharm Pract; 2021 Jan; 27(1):5-13. PubMed ID: 32237957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncology Pharmacist Opportunities: Closing the Gap in Quality Care.
    Vulaj V; Hough S; Bedard L; Farris K; Mackler E
    J Oncol Pract; 2018 Jun; 14(6):e403-e411. PubMed ID: 29298114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists.
    Haines SL; DeHart RM; Flynn AA; Hess KM; Marciniak MW; Mount J; Phillips BB; Saseen JJ; Zatzkin SW
    J Am Pharm Assoc (2003); 2011; 51(2):194-202. PubMed ID: 21382810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Developments in Pharmacists' Scope of Practice to Address Unmet Health Care Needs.
    Burns AL
    Ann Pharmacother; 2016 Sep; 50(9):785-7. PubMed ID: 27340143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educational strategies to enable expansion of pharmacogenomics-based care.
    Weitzel KW; Aquilante CL; Johnson S; Kisor DF; Empey PE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1986-1998. PubMed ID: 27864206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women in oncology pharmacy leadership: A white paper.
    Shillingburg A; Michaud LB; Schwartz R; Anderson J; Henry DW;
    J Oncol Pharm Pract; 2020 Jan; 26(1):175-186. PubMed ID: 31554471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building an outpatient cancer center pharmacy program across a tristate region.
    Skledar SJ; Doedyns A; Yourich B
    Am J Health Syst Pharm; 2015 Jan; 72(2):126-32. PubMed ID: 25550136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
    Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
    J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.